• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Bipolar disorder candidate gene, validated in mouse experiment

Bioengineer by Bioengineer
February 15, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: UNIST

A team of researchers, affiliated with UNIST has made a significant breakthrough in the search for the potential root causes of bipolar disorder.

The research team, led by Professor Pann-Ghill Suh of Life Sciences at UNIST conducted a study that suggests the cellular protein Phospholipase Cγ1 (PLCγ1) could be a new promising candidate gene for bipolar disorder, also known as manic-depressive illness.

The research published by the journal Molecular Psychiatry outlines the findings on January 31, 2017. The findings provide evidence that PLCγ1 is critical for synaptic function and plasticity and that the loss of PLCγ1 from the forebrain results in manic-like behavior. This breakthrough is expected to be widely used in research for the treatment ofthe manic symptoms associated with bipolar disorder.

The PLCγ1 has once been proposed as a candidate gene for bipolar disorder in previous studies. However, it has been unclear that how the PLCγ1 plays a role in neron-to-neuron signaling and how it is related to mental illnesses, like bipolar disorder.

In the study, Professor Suh and his team created forebrain-specific PLCγ1-deficient mice and observed what happened in the brain synapse of this mouse. Synapse is the part of the neuron where the signal is transmitted from the end.

To test whether dysfunction of PLCγ1 in the brain contributes to development of neuropsychiatric disorders, the research team generated mouse models, lacking PLCγ1 in the forebrain and studied the synaptic and neuronal changes in mouse models.

The research team reported that mice with forebrain-selective deletion of PLCγ1 also exhibit manic-like behavior, as well as deficits in inhibitory transmission and BDNF-dependent synaptic plasticity.

This resulted in the imbalance between excitatory and inhibitory synaptic transmission in forebrain circuits, leading to behavioral abnormalities and manic episodes of bipolar disorder. These symptoms were alleviated after the drug treatment for bipolar disorder was given.

"In the brain, excitatory synapses and inhibitory synapses work together to remain balanced for proper neurotransmission," says Professor Suh. "Our study demonstrated that the imbalance between these two is a major cause of various neuropsychiatric disorders and the GABAergic dysfunction observed in the hippocampi of bipolar disorder patients."

According to the research team, the inhibitory synapses that lacks PLCγ1 protein do not work properly in excitatory neurons. This is due to the improper signaling of BDNF, which is critical for the synapse formation. This leads to an imbalance of excitatory synapses and inhibitory synapses, and causes mental illnesses, like bipolar disorder.

"After 10 years of research, we have finally revealed PLCγ1 protein plays a major role in the onset of bipolar disorder," says Professor Suh. "Our findings, therefore, provide evidence that PLCγ1 is critical for synaptic function and plasticity and that the loss of PLCγ1 from the forebrain results in manic-like behavior."

###

The research was carried out with the support of the future creation science department and the Korea Research Foundation.

Journal Reference

Y R Yang, et al.,"Forebrain-specific ablation of phospholipase Cγ1 causes manic-like behavior," Molecular Psychiatry, (2017).

Media Contact

JooHyeon Heo
[email protected]
82-522-171-223

home

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026

Deep Learning Uncovers Tetrahydrocarbazoles as Potent Broad-Spectrum Antitumor Agents with Click-Activated Targeted Cancer Therapy Approach

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.